Dear Reader,

As we approach the end of 2015, and publish our final issue of Drugs—Real World Outcomes for the year, the editors and production staff at Adis wish to reflect on another successful year’s achievements and pay thanks to all those who have contributed their time and effort to guarantee the exceptional quality of our content.

We are delighted to have seen the conclusion of formalities surrounding the joint venture between Springer Science + Business Media with Nature Publishing Group, Palgrave Macmillan, Macmillan Education in early May. Substantial ground has already been made in the integration of business within the resulting Springer Nature company and we at Adis look eagerly toward the future, as the benefits of the collective expertise and capabilities of this company carry us forward.

The majority of our journals saw a rise in ISI impact factor against the previous year. Most notably, BioDrugs increased by 41 % to 2.989; the European Journal of Drug Metabolism and Pharmacokinetics increased 19 % to 1.563; CNS Drugs increased by 17 % to 5.113; Targeted Oncology increased 16 % to 4.000; Pediatric Drugs increased 15 % to 1.975; Drugs & Aging increased 13 % to 2.838; and Molecular Diagnosis & Therapy increased a further 12 % to 2.891, having already jumped 53 % in the preceding year. We hope to build upon these gains, once more, in 2016.

The Adis Book programme has grown substantially and 20 new titles will have been published over the course of the year. Over 50 further titles are currently in development with leading academics, internationally, and we continue to add more to the list. Our thanks, again, to all who have submitted these valuable proposals to date.

We offer our sincere thanks to all authors who have contributed articles to Drugs—Real World Outcomes since its inception in October 2014. Their skill and dedication are critical to the continued publication of the journal. The world-class quality of published articles is, similarly, testament to the significant efforts of the peer reviewers, whose commitment ensures that our content is held to the highest possible standard. In addition to the members of our Honorary Editorial Board, we would like to thank the following individuals who acted as reviewers for articles published in Drugs—Real World Outcomes in 2015:

Salah Al Awaidy, Oman

Davide Amato, Germany

Muhammad Amin, Pakistan

Claire W. Anderson, UK

Bernard Appiah, USA

Atsushi Araki, Japan

Anke Bahrmann, Germany

Vishal Bali, USA

Ghita Benabdallah, Morocco

Jose Ignacio Bernardino, Spain

Jean-Baptiste Beuscart, France

Patrick Blin, France

Felix Bochner, Australia

Gabrielle J Breugelmans, The Netherlands

Michael Broder, USA

Marta Brooks, USA

Daniel S Budnitz, USA

Michelle Cameron, USA

William J Canestaro, USA

Annalisa Capuano, Italy

Kathleen Carey, USA

Kathleen Carlson, USA

Ryan M Carnahan, USA

Ronald L Castelino, Australia

Jongwha Chang, USA

Chanadda Chinthammit, USA

Leslie Citrome, USA

Alice J Clark, Denmark

Barbara Clyne, Ireland

Mellar Davis, USA

Aditi Dey, Australia

Kelly Dunn, USA

Saeid Eslami, The Netherlands

Michele Faulkner, USA

Seyed-Mohammad Fereshtehnejad, Sweden

Mara Ferrara, Italy

James H Flory, USA

Annie Fourrier-Reglat, France

Lisa-Ann Fraser, Canada

Pietro Gareri, Italy

Pankti, Ajay, Gheewala, Australia

Ulrika Gillespie, Sweden

Christian Guilleminault, USA

Rachel Halpern, USA

Yasuo Hamamoto, Japan

Esra Hatipoglu, Turkey

Jennifer Havens, USA

Richard Hermann, USA

Keith D Hill, Australia

Jennifer Hirst, UK

Nico Hoertel, France

Koji Hori, Japan

Marcela Horvitz-Lennon, USA

Takashi Ichinomiya, Japan

Masfumi Ikeda, Japan

Tinte Itinteang, New Zealand

Gary Jackson, New Zealand

Philip Jacobs, Canada

Susan Jick, USA

Helgi Jung-Cook, Mexico

Johanna Jyrkkä, Finland

Pravin Kamble, USA

Joong-Seok Kim, Republic of Korea

Taro Kishi, Japan

Karel Kostev, Germany

Ines Krass, Australia

Santosh Kumar, USA

Ansgar Lange, Germany

Tamar Lasky, USA

Alejandro Lazo-Langner, Canada

Nicole Le Saux, Canada

Roberto Leone, Italy

Heather Limper, USA

Marianne Lisby, Denmark

Charlotta Ljungman, Sweden

Yoon Kong Loke, UK

Eve Lowestein, USA

Hendrika Luijendijk, The Netherlands

Brett Alyson Maiese, USA

David M Mannino, USA

Nariman Ahmad Mansur, Israel

Milka Maravic, France

Todd R Marcy, USA

Jaana Martikainen, Finland

Catia Marzolini, Switzerland

Karen Mate, Australia

Joey Mattingly, USA

Jose Mayordomo, Spain

Ushma Mehta, South Africa

Thomas Muller, Germany

Mercy Mvundura, USA

Mehdi Najafzadeh, Canada

Bjorn Erik Neerland, Norway

Dave Nellesen, USA

Tuan Anh Nguyen, Australia

Prasad S Nishtala, New Zealand

Rebecca Noel, USA

Kenneth Nugent, USA

Alexandra Cristina Pacurariu, The Netherlands

William Vincent Padula, USA

Lynne Parkinson, Australia

Paul PJ Perry, USA

Mathilde Pivette, France

Maurizio Pompili, Italy

Alexander Ponizovsky, USA

Joseph Proietto, Australia

Karen L Rascati, USA

Paul Reynolds, USA

John Robst, USA

Rosa Rodriguez-Monguio, USA

Bernd Rosenkranz, South Africa

Cheryl Sadowski, Canada

Morten Schmidt, Denmark

Catherine Sermet, France

Rashmi Shah, UK

Narjes Saheb Sharif-Askari, Malaysia

Karin Soderberg-lofdal, Sweden

Edoardo Spina, Italy

Wenqing Su, USA

Balamurugan Tangiisuran, Malaysia

Edward Thommes, Canada

Petra A Thurmann, Germany

Philippe Tuppin, France

Eric van Ganse, France

Florence van Hunsel, The Netherlands

Robert Vander Stichele, Belgium

Sotiris Vandoros, UK

Andreas Vilhelmsson, Sweden

Athanasios Vozikis, Greece

Louise Watson, UK

Tim Wehner, UK

Elisabeth Wells, New Zealand

Juanita Westbury, Australia

Tommy Westerlund, Sweden

Linda Wijlaars, UK

Gregg Wilkinson, USA

Quan Zou, USA

We hope that you have found the articles published throughout 2015 to be both interesting and informative. The editors have appreciated the high quality of content contributed to the journal this year and look forward to keeping you up to date with topical issues in the field of real world and big data in 2016.

With best wishes from the staff of Drugs—Real World Outcomes and all at Adis Publications.